Drawing for SMRT ROPE

USPTO serial 79332528

SMRT ROPE

Reviewed by CopyMark Law Group

Reg. 7008557Status 700Registered
Filing date
Status date
Registration date
Mar 28, 2023
Examiner
BROWN, TINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SMRT ROPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Stark

Matthew J. Stark Price Heneveld LLP695 Kenmoor SEGrand Rapids, MI 49546UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Stem cells for medical purposes; collagen for medical use; biodegradable implants comprising living tissue and collagen for use in guided tissue regeneration; implant materials for use in guided tissue regeneration in surgery, namely, implants comprising living tissue and collagen; implantable materials for use in guided tissue regeneration, namely, implants comprising living tissue and collagen; implants comprising living tissue and collagen for guided tissue regeneration; surgical implants comprising living tissue grown from stem cells; guided tissue regeneration materials, namely, biological tissue and collagen; biological preparations for medical purposes, namely, pharmaceutical preparations and substances for the treatment of damaged joints, tendons, ligaments, skin and tissue; tissues for medical use, namely, biological tissue grafts; surgical dressings incorporating collagen; surgical dressings made from collagen; tissue regenerative pharmaceutical preparations, namely, pharmaceutical preparations for regenerating tissue; tissues for surgical use, namely, implants comprising living tissue;, collagen based scaffolding for biomechanical support and stabilisation, namely, implantable scaffolds comprising living tissue and collagen for promoting integration of ligament into bone and ligamentisation; collagen based ligament substitutes, including for use in ACL construction being substitutes for ligaments comprising living tissue; none of the aforementioned goods being or in relation to genomics, sequencing of genomes, transcriptomes or epigenomes, medical diagnostic assays and reagents for use in genetic sequencing and biochemical analysisACTIVE—
010Artificial orthopaedic implants; biodegradable bone fixation implants; dental implants; medical implants made of artificial materials; orthopaedic implants made of artificial materials; surgical implants made of artificial materials for use in human medicine; surgical implants comprised of artificial materials; surgical implants comprised of artificial materials for replacing human tissue; surgical implants comprised of artificial materials for use in guided tissue regeneration; surgical prostheses, namely, joint, tendon and ligament prostheses; artificial skin for surgical purposes; artificial materials for use in guided tissue regeneration, namely, implants consisting of artificial materials; artificial replacement materials for human tissue, namely, human tissue grafts consisting of artificial materials; artificial replacement materials for animal tissue, namely, animal tissue grafts consisting of artificial materials; artificial ligament substitutes, including for use in ACL reconstructionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 7, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 19, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 19, 2023FIMPFINAL DISPOSITION PROCESSED—
Jun 28, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 28, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 28, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 25, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jan 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 12, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 12, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 12, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 23, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 30, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 30, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 29, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 28, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2022DOCKASSIGNED TO EXAMINER—
Feb 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance